Hite Hedge Asset Management LLC Abb Vie Inc. Transaction History

Hite Hedge Asset Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$85.91 - $100.83 $12,027 - $14,116	-140 Reduced 5.19%	2,560 $224,000
Q2 2020 Aug 14, 2020	BUY	$73.37 - $98.18 $198,099 - $265,086	2,700 New	2,700 $265,000
Q1 2020 May 14, 2020	SELL	$64.5 - $97.79 $165,120 - $250,342	-2,560 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$72.13 - $90.25 $184,652 - $231,040	2,560 New	2,560 $227,000
Q2 2019 Aug 13, 2019	SELL	$65.7 - $83.98 $168,192 - $214,988	-2,560 Closed	0 $0
Q3 2017 Nov 09, 2017	BUY	$69.85 - $89.22 $178,816 - $228,403	2,560	2,560 $227,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Hite Hedge Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Hite Hedge Asset Management LLC with notifications on news.